## NEM: Newmont Corporation - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 1.3% below STRENGTH zone (4.0-10.0%); PEG 2.25 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($84.18)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 1)

**1. Bull of the Day: Newmont (NEM)**
- Source: Finviz | 20251204T120838 | Bullish | Relevance: 100%
- Newmont (NEM) is highlighted as the Bull of the Day due to its strong performance amid a favorable gold market. The company, a Zacks Rank #1 (Strong Buy), has seen robust quarterly results, exceeding EPS estimates and achieving record Q3 free cash flow of $1.6 billion. This strong cash generation has enabled increased dividends and buybacks, making it an attractive investment.

**2. Newmont Stock (NEM) After December 3, 2025: Record Free Cash Flow, Job Cuts and Insider Selling â€“ Is There Still Upside?**
- Source: ts2.tech | 20251204T010727 | Somewhat-Bullish | Relevance: 100%
- Newmont Corporation (NEM) experienced a standout 2025, with its stock more than doubling in value after achieving record free cash flow, notably $1.6 billion in Q3 2025. The company is undergoing significant restructuring, including job cuts and a CEO transition, following its Newcrest acquisition, all while benefiting from near-record gold prices. Despite a recent insider stock sale and warnings about Q4 free cash flow, analysts generally maintain a bullish outlook, though with modest near-term upside expectations.

**3. Newmont (NYSE: NEM) director trades 2,080 shares under Rule 10b5-1 plan**
- Source: Stock Titan | 20251203T213500 | Somewhat-Bearish | Relevance: 100%
- A director at Newmont Corporation, Bruce R. Brook, reported selling 2,080 shares of Newmont common stock on December 1, 2025, at a price of $92.36 per share. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on September 3, 2024. Following the sale, the director directly owns 32,709 shares of Newmont common stock.

**4. Newmont (NEM): Reassessing Valuation After Strong Q3 Earnings, Record Gold Prices and Analyst Upgrades**
- Source: Simply Wall Street | 20251203T203406 | Bullish | Relevance: 100%
- Newmont (NEM) is experiencing a resurgence in value due to robust Q3 earnings, record gold prices, share buybacks, and a strong balance sheet, leading to a 117% stock increase this year and a 12.5% undervaluation based on a narrative fair value of $103.42. The company's recent acquisition of Newcrest Mining and ongoing expansion projects are expected to drive long-term revenue growth and cash flow stability. Investors are evaluating whether the market is still underestimating its cash flow power or has already factored in future growth.

**5. Can Newmont's Record Free Cash Flow Momentum Carry Into Q4?**
- Source: TradingView | 20251203T160645 | Bullish | Relevance: 100%
- Newmont Corporation logged a record quarterly free cash flow of $1.6 billion in Q3 2025, driven by increased operating activities, but faces potential declines in Q4 due to specific spending and payments. Despite short-term pressures, the company's strong balance sheet is expected to support growth and shareholder value. Peers like Barrick Mining Corporation and Agnico Eagle Mines Limited also reported significant free cash flow increases in the same period.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | UBS | $125 | $106 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($2.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (-1.1%)
- Blackrock Inc.: 11.2% (+3.4%)
- State Street Corpora: 4.5% (-0.3%)
- Geode Capital Manage: 2.4% (+3.9%)
- Van Eck Associates C: 2.2% (-42.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.25 elevated, pricing in significant growth expectations. Forward P/E 11.7x attractive for 23% earnings growth. Quality metrics strong (ROE 23%, ROA 10%, margin 33%). Balance sheet: strong liquidity (2.0x), $1.6B free cash flow. Analyst sentiment positive (1 raises, avg +18%). Insider selling cluster ($2.9M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $116.2B |
| Beta | 0.43 |
| 52W Range | $36.86 - $106.34 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.25 |
| Forward P/E | 11.7 |
| Current P/E | 14.4 |
| YoY Growth | 23.2% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 4.4% to 1.3% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.7pp (needs >4.0% for momentum thesis). MRS_5 (-0.4%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.4% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.28% (CS: 63) | Neutral |
| RSI_14 | 56.9 | Neutral |
| MACD Histogram | 0.38 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 1.391x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $90.72
- **Stop Loss:** $84.18 (7.2% risk)
- **Target:** $97.26 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 76
- **Position Value:** $6,894.72
- **Portfolio %:** 6.89%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-19 (Est: $1.79)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.44 | $1.71 | +18.8% |
| 2025Q2 | $1.16 | $1.43 | +22.9% |
| 2025Q1 | $0.91 | $1.25 | +37.1% |
| 2024Q4 | $1.03 | $1.40 | +35.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*